Cholestatic Hepatitis: Diagnostic Approach and Management
Initial Diagnostic Approach
- The American Association for the Study of Liver Diseases recommends beginning with abdominal ultrasound to differentiate intrahepatic from extrahepatic cholestasis, as this fundamental distinction drives all subsequent management decisions 1, 2, 3
- Ultrasound is mandatory as the initial non-invasive imaging to identify bile duct dilation and exclude mechanical obstruction 1, 3, 4
- If extrahepatic obstruction is suspected but therapeutic intervention is uncertain, proceed with MRCP or endoscopic ultrasound (EUS) rather than ERCP to avoid complications (bleeding 2%, cholangitis 1%, mortality 0.4%) 1, 2
Diagnostic Algorithm for Intrahepatic Cholestasis
- Test serum antimitochondrial antibodies (AMA) immediately in all adults with chronic intrahepatic cholestasis 1, 3, 4
- If AMA positive (≥1:40), diagnosis of primary biliary cholangitis (PBC) is confirmed with cholestatic enzyme profile and no alternative explanation 1, 4
- Perform MRCP at a specialized center for most patients with chronic intrahepatic cholestasis of unknown cause 1, 2, 3
- MRCP has 96-100% sensitivity for detecting bile duct stones 6
Management Strategies
- The European Association for the Study of the Liver recommends ursodeoxycholic acid (UDCA) as first-line therapy for PBC and various cholestatic liver diseases 7
- Monitor biochemical response after 1 year of UDCA therapy for risk stratification 5
- Endoscopic sphincterotomy and stone extraction for bile duct stones 5
- Endoscopic intervention for relevant strictures 5
Management of Complications
- Cholestyramine as first-line treatment for pruritus 5
- Rifampicin as second-line treatment for pruritus 5
- Naltrexone as third-line treatment for pruritus 5
- Correct fat-soluble vitamin deficiencies (A, D, E, K) 5
- Vitamin K supplementation when prothrombin time is prolonged 5